Results from a recent study found significant differences in the immune profile of African American patients with atopic dermatitis compared with European American patients.

News

News
Monday, May 23, 2016
IntraDerm Pharmaceuticals’ Ceramax skin barrier cream recently received FDA clearance as a topical skincare preparation to relieve and to manage the burning and itching associated with various dermatoses.
News
Thursday, February 18, 2016
Otsuka Pharmaceutical Co., Ltd. and Medimetriks Pharmaceuticals, Inc. entered into a licensing agreement granting Medimetriks exclusive US development and commercialization rights as well as manufacturing rights for OPA-15406, an investigational topical, non-steroidal phosphodiesterase IV (PDE-4) inhibitor, which is a new treatment class for atopic dermatitis.
News
Friday, March 13, 2015
All three products in its newest product line, CeraVe Baby (Valeant Pharmaceuticals North America LLC) have been awarded the National Eczema Association (NEA) Seal of Acceptance, which maintains rigorous standards for approval. Three-step skincare regimen was developed with pediatric dermatologists to help protect and maintain the skin barrier of babies.
News
Thursday, February 26, 2015
Recent study results with dupilumab, a fully-human monoclonal antibody against the interleukin-4 receptor-α, presented in a poster at American Academy of Allergy, Asthma, and Immunology1 annual meeting, demonstrated symptomatic efficacy in atopic dermatitis .

Research in Review

Research in Review
Wednesday, November 10, 2010
Research in Review
Thursday, July 29, 2010
New developments and controversies in pediatric dermatology. Data on new approaches to dermatological conditions affecting children and issues surrounding their treatment have recently been topics in the news and at meetings. Two new treatments for infantile hemangiomas that may offer a much-needed alternative to systemic corticosteroids are propranolol, a non-selective beta-adrenergic antagonist, and Timolol gel, a topical non-selective beta-adrenergic antagonist. Benzyl alcohol lotion 5% has emerged as a new first-line treatment for head lice. Acne-related issues include the fa
Research in Review
Wednesday, July 15, 2009
From bath products to clothing, children in the United States are being exposed to chemicals that we should be protecting them against. _____________________________ HISTORICAL PERSPECTIVE The earliest recorded description of allergic contact dermatitis (ACD) was documented in the first century AD by Pliny the Younger, who described an adult with “a severe itching from cutting pine trees.”1 While numerous anecdotal accounts of contact dermatitis exist through the literature,2 our working knowledge of the condition was first enlightened in 1895 by Josef Jadassohn, a